Comparison of efficacy and prognostic impact of adjuvant 131I therapy at 3.7 GBq and 5.55 GBq in DTC patients with unexplained sTg elevation

Comparison of efficacy and prognostic impact of adjuvant 131I therapy at 3.7 GBq and 5.55 GBq in DTC patients with unexplained sTg elevation

Abstract Background The optimal dose of adjuvant radioiodine(131I) therapy for differentiated thyroid cancer (DTC) remains controversial. This study aimed to determine the efficacy and prognostic impact of two doses of adjuvant 131I therapy (3.7 GBq and 5.55 GBq) in DTC patients with unexplained TSH...

Full description

Saved in:
Bibliographic Details
Main Authors: Nan Sun, Mengyue Liu, Chuang Xi, Quanyong Luo, Xiaoer Wei, Zhongling Qiu
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Cancer
Subjects:
Differentiated thyroid cancer
Radioiodine
Adjuvant therapy
Dosage
Efficacy
Online Access:https://doi.org/10.1186/s12885-025-14307-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14307-5

Similar Items